| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/01/1998 | EP0831798A1 Use of selegiline to treat hearing loss in mammals |
| 04/01/1998 | EP0831796A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors |
| 04/01/1998 | EP0831789A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| 04/01/1998 | EP0831726A1 Health food product |
| 04/01/1998 | EP0741707B1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
| 04/01/1998 | EP0625987B1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/01/1998 | EP0453515B1 Composition for treatment of senile dementia |
| 04/01/1998 | CN1177927A Extracts of shark cartilage, process of production and uses thereof |
| 04/01/1998 | CN1177596A Benzodihydropyran assorbic acid derivatives, their preparation and use |
| 03/31/1998 | US5734082 Hydroxyethyl aminimides |
| 03/31/1998 | US5734077 Antilipemic agents, anticholesterol agents, treatment of diabetes and atherosclerosis |
| 03/31/1998 | US5734046 Method for manufacturing limonoid glucosides |
| 03/31/1998 | US5734038 Purified polynucleotide sequence which codes for a diazepam binding inhibitor protein(or polypeptide) or an acyl-coenzyme a binding protein(or polypeptide) |
| 03/31/1998 | US5734037 DNA encoding the human cytokine, interleukin-9 |
| 03/31/1998 | US5733929 Pharmaceutical composition for treating or preventing allergic rhinitis |
| 03/31/1998 | US5733923 Secretory pancreatic phospholipase a2 |
| 03/31/1998 | US5733913 Treating atherosclerosis, postsurgical restenosis |
| 03/31/1998 | US5733912 Nervous system disorders in nerve cells |
| 03/31/1998 | US5733903 Treatment of neoplastic tissue by water-soluble texaphyrine metal complexes |
| 03/31/1998 | US5733897 Imidobisphosphoric acids, and use therefor |
| 03/31/1998 | US5733893 Binding of fibroblast growth factor to oligosaccharides |
| 03/31/1998 | US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 03/31/1998 | US5733562 Injectable medical device and method of use |
| 03/31/1998 | US5733558 Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same |
| 03/31/1998 | CA2134889C Calcium channel blocking polypeptides from filistata hibernalis |
| 03/27/1998 | CA2216479A1 Pharmaceutical formulations and methods for treating patients suffering from diseases that cause muscular hypotonia |
| 03/27/1998 | CA2214922A1 Benzothiophene compounds, compositions, and methods |
| 03/26/1998 | WO1998012328A2 Human bad polypeptides, encoding nucleic acids and methods of use |
| 03/26/1998 | WO1998012326A1 Hedgehog interacting proteins and uses related thereto |
| 03/26/1998 | WO1998012322A1 Bone morphogenetic protein-16 (bmp-16) compositions |
| 03/26/1998 | WO1998012228A1 Polymers containing polysaccharides such as alginates or modified alginates |
| 03/26/1998 | WO1998012223A1 Novel human interferon-inducible protein |
| 03/26/1998 | WO1998012220A2 Novel tumor proteins |
| 03/26/1998 | WO1998012211A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 03/26/1998 | WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | WO1998012204A1 Human b-cell translocation genes-2 and 3 |
| 03/26/1998 | WO1998012194A1 Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient |
| 03/26/1998 | WO1998012189A1 Method of producing polyphenol-containing compositions |
| 03/26/1998 | WO1998012177A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 03/26/1998 | WO1998011923A1 Identification of agents that protect against inflammatory injury to neurons |
| 03/26/1998 | WO1998011906A1 Phospholipid drug derivatives |
| 03/26/1998 | WO1998011901A1 Inositol polyphosphate derivatives and methods of using same |
| 03/26/1998 | WO1998011789A1 Flavonol containing food supplements |
| 03/26/1998 | WO1998006400A3 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
| 03/26/1998 | WO1998005338A3 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| 03/26/1998 | WO1997046672A3 Antisense nucleic acids and hammerhead ribozymes |
| 03/26/1998 | DE19639103A1 DNA construct with inhibitory mutation and corrective mutation |
| 03/26/1998 | CA2267348A1 Inositol polyphosphate derivatives and methods of using same |
| 03/26/1998 | CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | CA2266447A1 Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient |
| 03/26/1998 | CA2266425A1 Human b-cell translocation genes-2 and 3 |
| 03/26/1998 | CA2266404A1 Phospholipid drug derivatives |
| 03/26/1998 | CA2265896A1 Identification of agents that protect against inflammatory injury to neurons |
| 03/26/1998 | CA2263821A1 Novel human interferon-inducible protein |
| 03/26/1998 | CA2263818A1 Novel tumor proteins |
| 03/26/1998 | CA2215856A1 Dihydrobenzofluorene compounds, intermediates, compositions, and methods |
| 03/26/1998 | CA2214935A1 Benzofluorene compounds, intermediates, compositions, and methods |
| 03/26/1998 | CA2214931A1 Tetrahydrobenzo-a-fluorene compounds and method of use |
| 03/26/1998 | CA2214196A1 Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods |
| 03/26/1998 | CA2214176A1 Dihydrobenzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods |
| 03/25/1998 | EP0831090A1 N-substituted cyclic amines, process for their preparation and pharmaceutical compositions containing them |
| 03/25/1998 | EP0831089A1 Benzothiophene compounds, intermediates, processes, compositions, and methods |
| 03/25/1998 | EP0830861A1 Use of PKC inhibitors for the manufacture of a medicament for the treatment of HTLV-1 infections |
| 03/25/1998 | EP0830860A1 Use of PKC inhibitors for the manufacture of a medicament for the treatment of AIDS |
| 03/25/1998 | EP0830604A1 Methods and uses for apoptin |
| 03/25/1998 | EP0830352A1 Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 03/25/1998 | EP0830348A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 03/25/1998 | EP0830347A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 03/25/1998 | EP0830346A1 2-substituted benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 03/25/1998 | EP0830345A1 Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 03/25/1998 | EP0830344A1 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors |
| 03/25/1998 | EP0830343A1 Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 03/25/1998 | EP0830138A1 Use of fibroblast growth factors to stimulate bone growth |
| 03/25/1998 | EP0830136A1 New cryptophycins from synthesis |
| 03/25/1998 | EP0830131A1 New pharmacological use of aii-receptor antagonists |
| 03/25/1998 | EP0830130A1 Tnf-alpha converting enzyme |
| 03/25/1998 | EP0802791A4 3,3-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds |
| 03/25/1998 | EP0799204A4 1,3,3-(trisubstituted)cyclohexane monomers and related compounds |
| 03/25/1998 | EP0799186A4 1,4,4-(trisubstituted)cyclohex-1-ene dimers and related compounds |
| 03/25/1998 | EP0799185A4 1,3,3-(trisubstituted)cyclohexane dimers and related compounds |
| 03/25/1998 | EP0799184A4 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds |
| 03/25/1998 | EP0799182A4 3,3-(disubstituted)cyclohexan-1-ol dimers and related compounds |
| 03/25/1998 | EP0799181A4 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds |
| 03/25/1998 | EP0799036A4 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds |
| 03/25/1998 | EP0799031A4 1,4,4-(trisubstituted)cyclohexane dimers and related compounds |
| 03/25/1998 | EP0796097A4 3,3-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
| 03/25/1998 | CN1177349A Certain 4 -aminomethyl -2 -substituted imidazole derivatives and 2 -aminomethyl -4 -substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
| 03/25/1998 | CN1177343A Cell adhesion inhibitors |
| 03/25/1998 | CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine |
| 03/25/1998 | CN1177297A Medicament interded to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfuctions emesa and transport sickness |
| 03/25/1998 | CN1176964A New benzimidazole derivatives with antihistaminic activity |
| 03/25/1998 | CN1037842C Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 03/24/1998 | US5731441 Hydroxamic acid derivatives with tricyclic substitution |
| 03/24/1998 | US5731436 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
| 03/24/1998 | US5731432 Inhibitors of adenosine monophosphate deaminase |
| 03/24/1998 | US5731413 Liquid or solid phase biosynthesis |
| 03/24/1998 | US5731351 Antiarrhythmia agents |
| 03/24/1998 | US5731350 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/24/1998 | US5731340 Dietetics; antidiabetic agents |
| 03/24/1998 | US5731337 Conformationally rigid bicycle and adamantane derivatives useful as α2 |